Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 8.88
-0.44 (-4.72%)
Aug 26, 2026, 1:09 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 894.5 million as of August 26, 2026. Its market cap has decreased by -39.84% in one year.
Market Cap
894.50M
Enterprise Value
1.79B
Revenue
408.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.88
ChartMarket Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 894.50M, a decrease of -54.04%. That is a compound annual growth rate of -21.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 894.50M | -37.81% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.13B |
| LabTurbo Biotech | 1.12B |
| Bio Preventive Medicine | 1.09B |
| Lukas Biomedical | 1.03B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 979.88M |
| Holy Stone Healthcare | 978.03M |
| TCI GENE | 899.59M |